FDA Grants 510(k) Clearance for Blue Belt Technologies’ STRIDE Knee Implant

Blue Belt Technologies received 510(k) clearance from the U.S. Food and Drug Administration for its STRIDE Unicondylar Knee implant.

Advertisement

The STRIDE implant will be marketed with the company’s NavioPFS system. The knee system is designed to treat medial and lateral compartment osteoarthritis.

More Articles on Devices:
TranS1 Renamed Baxano Surgical, Relocates Headquarters to Raleigh
SI-BONE Releases Data on 5,319 Patients Treated With iFuse Implant System
6 Device Company Acquisitions & Partnerships

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.